Stamlo Trio 40/6.25 Tablet
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (6.25mg)
Overview Stamlo Trio 40/6.25 Tablet
Hypertensive patients for whom monotherapy proves insufficient may benefit from Triamlo 40/6.25, a multi-component tablet. This formulation effectively manages elevated blood pressure, consequently diminishing the likelihood of cerebrovascular accidents and myocardial infarctions. Administer Triamlo 40/6.25 with food, adhering to a consistent daily schedule as prescribed by your physician. Dosage is individualized based on patient response and underlying health status. Continuous use is crucial, ceasing only upon medical instruction. Due to its diuretic component, avoid ingestion within four hours of bedtime to minimize nocturnal urination. Regular use, even during symptom-free periods, optimizes therapeutic efficacy. Untreated hypertension often presents asymptomatically; discontinuation increases the risk of serious cardiovascular events. Commonly reported adverse effects encompass edema (ankle swelling), cephalalgia (headache), vertigo (dizziness), lassitude (fatigue), and altered gustatory perception (taste changes). Report any persistent, worsening, or bothersome side effects to your physician. Maintain adequate hydration to mitigate potential side effects such as myalgia (muscle weakness), xerostomia (dry mouth), and polydipsia (extreme thirst). Prior to commencing treatment, disclose any renal or hepatic impairment. Pregnant or lactating individuals should seek medical guidance before initiating Triamlo 40/6.25. Complete disclosure of all concurrent medications, particularly those targeting hypertension or cardiac conditions, is essential. Routine monitoring of blood pressure, renal function, electrolyte balance, and glycemia is necessary to ensure optimal therapeutic response and safety.
Uses of Stamlo Trio 40/6.25 Tablet
Elevated blood pressure
Major Benefits of Stamlo Trio 40/6.25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Stamlo Trio 40/6.25 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Stamlo Trio 40/6.25 Tablet:
- Headache
- Dizziness
- Sleepiness
- Edema (swelling)
- Increased uric acid level in blood
- Fatigue
- Increased blood lipid level
- Increased liver enzymes
- Visual disturbance
- Breathlessness
- Muscle cramp
- Gastrointestinal disturbance
- Electrolyte imbalance
- Increased glucose level in blood
- Urticaria
- Postural hypotension (low blood pressure)
- Impotence
How to use Stamlo Trio 40/6.25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Stamlo Trio 40/6.25 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Stamlo Trio 40/6.25 Tablet works:
Stamlo Trio 40/6.25 tablets contain telmisartan, amlodipine, and chlorthalidone, three medications working synergistically to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both promote vasodilation, reducing vascular resistance and consequently blood pressure. Chlorthalidone, a diuretic, facilitates fluid excretion, eliminating excess water and electrolytes, and contributes to long-term vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Stamlo Trio 40/6.25 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Stamlo Trio 40/6.25 tablets during pregnancy poses a confirmed risk to the fetus. Prescribing this medication during pregnancy is uncommon, reserved only for life-threatening conditions where potential benefits outweigh the known dangers. Always seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Employing Stamlo Trio 40/6.25 tablets while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant hazard from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Stamlo Trio 40/6.25 Tablets. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and driving aptitude.
KidneyCAUTION
Patients with severe kidney impairment should use Stamlo Trio 40/6.25 tablets cautiously, potentially requiring dosage modification. Physician consultation is advised; this medication is generally unsuitable for such individuals.
LiverCAUTION
Patients with liver impairment should use Stamlo Trio 40/6.25 tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Stamlo Trio 40/6.25 tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Stamlo Trio 40/6.25 Tablet :
Should you forget to take your Stamlo Trio 40/6.25 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.
Facts to Know About Stamlo Trio 40/6.25 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





